Search research articles
Contact Us
Filters
Showing results (301-310 of 306) with videos related to
Page
of 31
Sort By:
You have reached the last page of results.
This site can display upto 306 results.
The New England Journal of Medicine
|
July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Journal for Immunotherapy of Cancer
|
December 27, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
Michael Boyiadzis, Michael R Bishop, Rafat Abonour, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
The Lancet. Haematology
|
October 11, 2024
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
Rami S Komrokji, Luca Lanino, Somedeb Ball, et al.
Hemasphere
|
June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Page
of 31
Search research articles
Search
Showing results (301-310 of 306) with videos related to
Sort By:
Page
of 31
You have reached the last page of results.
This site can display upto 306 results.
The New England Journal of Medicine
|
July 24, 2024
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults
Mark R Litzow, Zhuoxin Sun, Ryan J Mattison, et al.
Blood Reviews
|
September 13, 2023
Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)
Maximilian Stahl, Jan Philipp Bewersdorf, Zhuoer Xie, et al.
Journal for Immunotherapy of Cancer
|
December 27, 2016
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia
Michael Boyiadzis, Michael R Bishop, Rafat Abonour, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
September 25, 2024
Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes-Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])
Fnu Aakash, Savanah D Gisriel, Amer M Zeidan, et al.
The Lancet. Haematology
|
October 11, 2024
Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes
Rami S Komrokji, Luca Lanino, Somedeb Ball, et al.
Hemasphere
|
June 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
Giulia Maggioni, Gabriele Todisco, Elisabetta Sauta, et al.
Page
of 31